Back
Speaker illustration

Doctor Arnold Peter Raduly

University of Debrecen, Faculty of Medicine, Debrecen (Hungary)

Presentations

The novel myosin activator, danicamtiv alters both systolic and diastolic functions in vitro and in vivo

Event: Heart Failure 2024

Topic: Heart Failure

Session: ePosters in basic science 2

Access
Like
Thumbnail

ESC 365 is supported by

novartis Explore sponsored resources